IFNG and neoplasm: Ex-vivo analysis shows that at the peak of the anti-melanoma effector response, melanoma specific Pmel-1 T cells are primed into competent effector cells (shown by surface phenotype, IFNγ secretion and lytic capacity in the periphery) but are unable to mediate tumor regression.